|
|
||||||||
Department of Physiology, Tulane University School of Medicine, New Orleans, Louisiana 70112
We have studied
cardiovascular and renal phenotypes in Npr1 (genetic determinant of
natriuretic peptide receptor-A; NPRA) gene-disrupted mutant mouse
model. The baseline systolic arterial pressure (SAP) in 0-copy mutant
(
/
) mice (143 ± 2 mmHg) was significantly higher than in
2-copy wild-type (+/+) animals (104 ± 2 mmHg); however, the SAP
in 1-copy heterozygotes (+/
) was at an intermediate value (120 ± 4 mmHg). To determine whether Npr1 gene function affects the
renin-angiotensin-aldosterone system (RAAS), we measured the components
of RAAS in plasma, kidney, and adrenal gland of 0-copy, 1-copy, and
2-copy male mice. Newborn (2 days after the birth) 0-copy pups showed
2.5-fold higher intrarenal renin contents compared with 2-copy
wild-type counterparts (0-copy 72 ± 12 vs. 2-copy 30 ± 7 µg ANG I · mg
protein
1 · h
1, respectively). The
intrarenal ANG II level in 0-copy pups was also higher than in 2-copy
controls (0-copy 33 ± 5 vs. 2-copy 20 ± 2 pg/mg protein,
respectively). However, both young (3 wk) and adult (16 wk) 0-copy
mutant mice showed a dramatic 50-80% reduction in plasma renin
concentrations (PRCs) and in expression of renal renin message compared
with 2-copy control animals. In contrast, the adrenal renin content and
mRNA expression levels were 1.5- to 2-fold higher in 0-copy adult mice
than in 2-copy animals. The results suggest that inhibition of renal
and systemic RAAS is a compensatory response that prevents greater
increases in elevated arterial pressures in adult NPRA null mutant
mice. However, the greater renin and ANG II levels seen in 0-copy
newborn pups provide evidence that the direct effect of NPRA activation on renin is an inhibitory response.
guanylyl cyclase A; gene targeting; renin-angiotensin-aldosterone system; renin activity; natriuretic peptide receptor-A gene-deficient mice
This article has been cited by other articles:
![]() |
E. Vellaichamy, D. Zhao, N. Somanna, and K. N. Pandey Genetic disruption of guanylyl cyclase/natriuretic peptide receptor-A upregulates ACE and AT1 receptor gene expression and signaling: role in cardiac hypertrophy Physiol Genomics, October 19, 2007; 31(2): 193 - 202. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Zhao, E. Vellaichamy, N. K. Somanna, and K. N. Pandey Guanylyl cyclase/natriuretic peptide receptor-A gene disruption causes increased adrenal angiotensin II and aldosterone levels Am J Physiol Renal Physiol, July 1, 2007; 293(1): F121 - F127. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Franco and S. Oparil Salt sensitivity, a determinant of blood pressure, cardiovascular disease and survival. J. Am. Coll. Nutr., June 1, 2006; 25(3 Suppl): 247S - 255S. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. J. Mullins, M. A. Bailey, and J. J. Mullins Hypertension, Kidney, and Transgenics: A Fresh Perspective Physiol Rev, April 1, 2006; 86(2): 709 - 746. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Ge, D. Ahn, P. K. Stricklett, A. K. Hughes, M. Yanagisawa, J. G. Verbalis, and D. E. Kohan Collecting duct-specific knockout of endothelin-1 alters vasopressin regulation of urine osmolality Am J Physiol Renal Physiol, May 1, 2005; 288(5): F912 - F920. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Nishikimi, J. R. Hagaman, N. Takahashi, H.-S. Kim, H. Matsuoka, O. Smithies, and N. Maeda Increased susceptibility to heart failure in response to volume overload in mice lacking natriuretic peptide receptor-A gene Cardiovasc Res, April 1, 2005; 66(1): 94 - 103. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-J. Shi, E. Vellaichamy, S. Y. Chin, O. Smithies, L. G. Navar, and K. N. Pandey Natriuretic peptide receptor A mediates renal sodium excretory responses to blood volume expansion Am J Physiol Renal Physiol, October 1, 2003; 285(4): F694 - F702. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |